
|Videos|March 24, 2023
Use of Spesolimab in the Treatment of GPP
Author(s)Raj Chovatiya, MD, PhD, MSCI
Dr Raj Chovatiya discusses a recently approved therapeutic agent, spesolimab, as a valuable addition to the GPP treatment landscape.
Advertisement
Episodes in this series

Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
2
Delgocitinib Offers Targeted Relief for the Painful Burden of Chronic Hand Eczema
3
Top 5 Articles of the Week: December 7-12
4
Dermatology Times Spot Test: December 14, 2025
5





















